Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-10-06

FDA Approved: NALOXONE HYDROCHLORIDE — Original Application (BPI Labs LLC)

View source ↗

Summary

FDA approved the original application for naloxone hydrochloride from BPI Labs LLC, making a generic naloxone product available for opioid overdose treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

ORIG AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)